Maxlen-70 Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Alendronate Na trihydrate

Indications/Uses

Treatment & prevention of postmenopausal osteoporosis; glucocorticoid-induced osteoporosis & Paget's bone disease in men & women; to increase bone mass in men w/ osteoporosis.

Click to view Maxlen-70 detailed prescribing information

Dosage/Direction for Use

1 tab once wkly.

Click to view Maxlen-70 detailed prescribing information

Overdosage

View Maxlen-70 overdosage for action to be taken in the event of an overdose.

Administration

Should be taken on an empty stomach: Take at least 30 min before the 1st food/drink/medication of the day w/ a full glass of plain water & remain in sitting/upright position for at least 30 min. Swallow whole, do not chew/crush.

Contraindications

Hypersensitivity. Patients w/ abnormalities of the oesophagus & other factors which delay oesophageal emptying eg stricture or achalasia; inability to stand or sit upright for at least 30 min; hypocalcemia. Childn. Lactation.

Click to view Maxlen-70 detailed prescribing information

Special Precautions

Patients w/ active upper GI problems eg dysphagia, oesophageal disease, gastritis, duodenitis, ulcers or major GI disease. Discontinue treatment if symptoms of oesophageal irritation develop. Avoid invasive dental procedures during treatment. Correct hypocalcemia & other disorders affecting mineral metabolism prior to treatment & monitor these conditions during therapy. Renal impairment (GFR<35 mL/min). Pregnancy.

Click to view Maxlen-70 detailed prescribing information

Use In Pregnancy & Lactation

Click to view Maxlen-70 detailed prescribing information

Adverse Reactions

Headache, abdominal pain, dyspepsia, constipation, diarrhea, flatulence, oesophageal ulcer, dysphagia, abdominal distention, acid regurgitation; musculoskeletal (bone, muscle or joint) pain.

Click to view Maxlen-70 detailed prescribing information

Drug Interactions

Ca supplements, antacids & other oral medicinal products may interfere w/ absorption of alendronate.

Click to view Maxlen-70 detailed prescribing information

Storage

View Maxlen-70 storage conditions for details to ensure optimal shelf-life.

Description

View Maxlen-70 description for details of the chemical structure and excipients (inactive components).

Action

View Maxlen-70 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BA04 - alendronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Maxlen-70 tab 70 mg

Packing/Price

4's

Maxlen-70

alendronic acid

Manufacturer:

Mega Lifesciences

Distributor:

Maxxcare